Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA1 | P30542 | 2/20 | 0.60 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.60 |
| ▸ | YTHDC1 | Q96MU7 | 2/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.46 |
| ▸ | PKM | P14618 | 1/20 | 0.46 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.46 |
| ▸ | THPO | P40225 | 1/20 | 0.46 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.46 |
| ▸ | CDK1 | P06493 | 2/20 | 0.46 |
| ▸ | FDPS | P14324 | 1/20 | 0.44 |
| ▸ | P2RX7 | Q99572 | 2/20 | 0.42 |
| ▸ | FGFR1 | P11362 | 2/20 | 0.40 |
| ▸ | FGFR4 | P22455 | 2/20 | 0.40 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30572667 | 1.00 | ADORA1 (0.60) | ADORA1ADORA2AYTHDC1CYP1A2CYP3A4 | |
| SCHEMBL441875 | 0.77 | ADORA1 (0.62) | ADORA1ADORA2AYTHDC1CYP1A2CYP3A4 | |
| SCHEMBL6670287 | 0.76 | FDPS (0.42) | ADORA1ADORA2AYTHDC1FDPSP2RX7 | |
| SCHEMBL23436498 | 0.76 | ADORA2A (0.66) | ADORA1ADORA2ACYP1A2CYP2D6FDPS | |
| SCHEMBL106573 | 0.75 | ADORA2A (1.00) | ADORA1ADORA2AYTHDC1CDK1 | |
| SCHEMBL10910542 | 0.75 | FDPS (0.47) | ADORA1ADORA2AFDPSP2RX7FGFR1 | |
| SCHEMBL5801450 | 0.75 | ADORA1 (0.60) | ADORA1ADORA2AYTHDC1CYP1A2CYP3A4 | |
| SCHEMBL1868819 | 0.75 | FDPS (0.44) | ADORA1ADORA2AFDPSP2RX7FGFR1 | |
| SCHEMBL3857168 | 0.75 | ADORA1 (0.60) | ADORA1ADORA2AYTHDC1CYP1A2CYP3A4 | |
| SCHEMBL18721931 | 0.75 | ADORA1 (0.60) | ADORA1ADORA2AYTHDC1CYP1A2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 197 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115251068-B | Growth regulating composition special for tomatoes | 凯盛浩丰农业集团有限公司 | 2023-11-14 | — | — | CN | claimed |
| CN-115251068-A | Special growth regulating composition for tomatoes | 凯盛浩丰农业有限公司 | 2022-11-01 | — | — | CN | claimed |
| CN-118632843-A | Pyridine derivative and application thereof | 四川汇宇制药股份有限公司 | 2024-09-10 | — | — | CN | disclosed |
| WO-2024049929-A2 | PANNEXIN-1 MODULATORS AND METHODS OF TREATING DISORDERS IN WHICH PANNEXIN-1 IS IMPLICATED | PANNEX THERAPEUTICS INC. (US) | 2024-03-07 | — | — | WO | disclosed |
| US-11858907-B2 | Kinase modulators | RHIZEN PHARMACEUTICALS AG (CH) | 2024-01-02 | — | — | US | disclosed |
| CN-117279911-A | Heterocyclic compound and application thereof | 深圳微芯生物科技股份有限公司 | 2023-12-22 | — | — | CN | disclosed |
| EP-3728283-B1 | 3'3' CYCLIC DINUCLEOTIDES WITH PHOSPHONATE BOND ACTIVATING THE STING ADAPTOR PROTEIN | INST OF ORGANIC CHEMISTRY AND BIOCHEMISTRY ASCR V V I (CZ) | 2023-11-22 | — | — | EP | disclosed |
| CN-115251068-B | Growth regulating composition special for tomatoes | 凯盛浩丰农业集团有限公司 | 2023-11-14 | — | — | CN | disclosed |
| US-20230303613-A1 | 3′3′ CYCLIC DINUCLEOTIDES WITH AN ALKENYLENE | INSTITUTE OF ORGANIC CHEMISTRY AND BIOCHEMISTRY AS CR, V.V.I. (CZ) | 2023-09-28 | — | — | US | disclosed |
| US-20230303613-A1 | 3′3′ CYCLIC DINUCLEOTIDES WITH AN ALKENYLENE | INSTITUTE OF ORGANIC CHEMISTRY AND BIOCHEMISTRY AS CR, V.V.I. (CZ) | 2023-09-28 | — | — | US | disclosed |
| WO-2023165581-A1 | PYRIDINE DERIVATIVE AND USE THEREOF | 四川汇宇制药股份有限公司 | 2023-09-07 | — | — | WO | disclosed |
| EP-0778836-A4 | SUBSTITUTED 9-ALKYLADENINES | DISCOVERY THERAPEUTICS INC (US) | 1998-02-04 | — | — | EP | disclosed |
| US-5670501-A | USEFUL AS DIURETICS, TREATING RENAL DISORDERS, RESTORING CARDIAC FUNCTIONS | DISCOVERY THERAPEUTICS, INC. (US) | 1997-09-23 | — | — | US | disclosed |
| EP-0778836-A1 | SUBSTITUTED 9-ALKYLADENINES | Discovery Therapeutics, Inc. (US) | 1997-06-18 | — | — | EP | disclosed |
| US-5571819-A | Imidazopyridines as muscarinic agents | WYETH | 1996-11-05 | — | — | US | disclosed |
| WO-1996006845-A1 | SUBSTITUTED 9-ALKYLADENINES | DISCOVERY THERAPEUTICS, INC. (US) | 1996-03-07 | — | — | WO | disclosed |
| EP-0300726-B1 | PIPERAZINYL DERIVATES OF PURINES AND ISOSTERES THEREOF AS HYPOGLYCEMIC AGENTS | MERCK & CO. INC. (US) | 1993-09-22 | — | — | EP | disclosed |
| WO-1993018035-A1 | ANGIOTENSIN II RECEPTOR ANTAGONISTS | ABBOTT LABORATORIES (US) | 1993-09-16 | — | — | WO | disclosed |
| US-5057517-A | Piperazinyl derivatives of purines and isosteres thereof as hypoglycemic agents | MERCK & CO., INC. (US) | 1991-10-15 | — | — | US | disclosed |
| EP-0300726-A1 | Piperazinyl derivates of purines and isosteres thereof as hypoglycemic agents | MERCK & CO. INC. (US) | 1989-01-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11858907-B2 | Kinase modulators | RPS6KA1, RPS6KA2, PRKAR2A | ADORA1 1608/4885ADORA2A 1129/4885YTHDC1 4656/4885 |
| US-20230303613-A1 | 3′3′ CYCLIC DINUCLEOTIDES WITH AN ALKENYLENE | STING1, CGAS, IRF3 | ADORA1 217/4885ADORA2A 237/4885YTHDC1 3243/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.